Who Paid My Doc
Zepatier
Drug Infectious Disease
NDC 0006-3074-02
General payments
$2,263
Research payments
$1,142,868
Through program year 2025, $2,263 in general payments and $1,142,868 in research payments were reported against Zepatier (Infectious Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $32,420 | 2 |
| 2024 | Research | $138,775 | 2 |
| 2023 | Research | $174,546 | 2 |
| 2022 | Research | $24,960 | 1 |
| 2021 | Research | $184,475 | 5 |
| 2020 | Research | $169,630 | 4 |
| 2019 | General | $2,263 | 47 |
| 2019 | Research | $418,062 | 7 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2019.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
47 general · 23 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.